147 related articles for article (PubMed ID: 18058237)
1. Expression of p16(INK4A) gene in human pituitary tumours.
Machiavelli G; Cotignola J; Danilowicz K; Carbonara C; Paes de Lima A; Basso A; Bruno OD; Szijan I
Pituitary; 2008; 11(1):71-5. PubMed ID: 18058237
[TBL] [Abstract][Full Text] [Related]
2. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas.
Ogino A; Yoshino A; Katayama Y; Watanabe T; Ota T; Komine C; Yokoyama T; Fukushima T
J Neuropathol Exp Neurol; 2005 May; 64(5):398-403. PubMed ID: 15892297
[TBL] [Abstract][Full Text] [Related]
3. p16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumours.
Jaffrain-Rea ML; Ferretti E; Toniato E; Cannita K; Santoro A; Di Stefano D; Ricevuto E; Maroder M; Tamburrano G; Cantore G; Gulino A; Martinotti S
Clin Endocrinol (Oxf); 1999 Sep; 51(3):317-25. PubMed ID: 10469011
[TBL] [Abstract][Full Text] [Related]
4. CDKN2A/p16 inactivation is related to pituitary adenoma type and size.
Seemann N; Kuhn D; Wrocklage C; Keyvani K; Hackl W; Buchfelder M; Fahlbusch R; Paulus W
J Pathol; 2001 Apr; 193(4):491-7. PubMed ID: 11276008
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas.
Yoshino A; Katayama Y; Ogino A; Watanabe T; Yachi K; Ohta T; Komine C; Yokoyama T; Fukushima T
J Neurooncol; 2007 Jun; 83(2):153-62. PubMed ID: 17216555
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of CDKN2A and suppression of cyclin D1 gene expressions in ACTH-secreting pituitary adenomas.
Tani Y; Inoshita N; Sugiyama T; Kato M; Yamada S; Shichiri M; Hirata Y
Eur J Endocrinol; 2010 Oct; 163(4):523-9. PubMed ID: 20616110
[TBL] [Abstract][Full Text] [Related]
7. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A
J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of p16(INK4a) in azoxymethane-induced mouse colon tumorigenesis.
Wang QS; Papanikolaou A; Nambiar PR; Rosenberg DW
Mol Carcinog; 2000 Jul; 28(3):139-47. PubMed ID: 10942530
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of G(1)/S regulators is a frequent event in sporadic pituitary adenomas.
Simpson DJ; Frost SJ; Bicknell JE; Broome JC; McNicol AM; Clayton RN; Farrell WE
Carcinogenesis; 2001 Aug; 22(8):1149-54. PubMed ID: 11470742
[TBL] [Abstract][Full Text] [Related]
10. P16 overexpression in pituitary adenomas studied by immunohistochemistry and in situ hybridization.
Yi J; Yu D; Chen Y; Xiong W; Li X; Shen J; Tang X
Chin Med J (Engl); 2000 Feb; 113(2):162-6. PubMed ID: 11775544
[TBL] [Abstract][Full Text] [Related]
11. Expression of p18(INK4C) is down-regulated in human pituitary adenomas.
Hossain MG; Iwata T; Mizusawa N; Qian ZR; Shima SW; Okutsu T; Yamada S; Sano T; Yoshimoto K
Endocr Pathol; 2009; 20(2):114-21. PubMed ID: 19401813
[TBL] [Abstract][Full Text] [Related]
12. Differential gene expression in pituitary adenomas by oligonucleotide array analysis.
Morris DG; Musat M; Czirják S; Hanzély Z; Lillington DM; Korbonits M; Grossman AB
Eur J Endocrinol; 2005 Jul; 153(1):143-51. PubMed ID: 15994756
[TBL] [Abstract][Full Text] [Related]
13. Expression of neuro D1 in human normal pituitaries and pituitary adenomas.
Oyama K; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary study of p16 gene expression in pituitary adenomas].
Yu WH; Hui GZ; Wang Q; Wu SR
Ai Zheng; 2003 Feb; 22(2):198-201. PubMed ID: 12600300
[TBL] [Abstract][Full Text] [Related]
15. Oncogene-induced senescence in pituitary adenomas and carcinomas.
Alexandraki KI; Munayem Khan M; Chahal HS; Dalantaeva NS; Trivellin G; Berney DM; Caron P; Popovic V; Pfeifer M; Jordan S; Korbonits M; Grossman AB
Hormones (Athens); 2012; 11(3):297-307. PubMed ID: 22908062
[TBL] [Abstract][Full Text] [Related]
16. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
[TBL] [Abstract][Full Text] [Related]
17. The Clinical Utility of TIMP3 Expression in ACTH-Secreting Pituitary Tumor.
Sun B; Liu X; Yang Y; Dai C; Li Y; Jiao Y; Wei Z; Yao Y; Feng M; Bao X; Deng K; Wang N; Wang R
J Mol Neurosci; 2016 Jan; 58(1):137-44. PubMed ID: 26676407
[TBL] [Abstract][Full Text] [Related]
18. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
[TBL] [Abstract][Full Text] [Related]
19. Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours.
Kaltsas GA; Kola B; Borboli N; Morris DG; Gueorguiev M; Swords FM; Czirják S; Kirschner LS; Stratakis CA; Korbonits M; Grossman AB
Clin Endocrinol (Oxf); 2002 Oct; 57(4):443-8. PubMed ID: 12354125
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of the p16 gene in human pituitary nonfunctioning tumors by hypermethylation is more common in null cell adenomas.
Ruebel KH; Jin L; Zhang S; Scheithauer BW; Lloyd RV
Endocr Pathol; 2001; 12(3):281-9. PubMed ID: 11740049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
